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Summary Cervical carcinomas are closely associated with high-risk human papillomavirus (HPV) types and are preceded by cervical
intraepithelial neoplasia (CIN). Most CIN lesions regress spontaneously and will not evolve to invasive carcinoma. The cellular immune
system mediated by cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells are thought to play an important role in the ultimate decline
of CIN lesions. Although TIA-1 is constitutively expressed in the majority ofcirculating Tcells and defines asubpopulation of CD8+Tcells with
cytotoxic potential, granzyme B is only expressed in CTLs upon activation. In the present study we have evaluated the expression of these
proteins by lymphocytes present in 24 randomly chosen CIN lesions with increasing degree of atypia and in 14 cervical squamous cell
carcinomas. As major histocompatibility complex (MHC) class I expression is frequently down-regulated in HPV-induced lesions, thus
possibly frustrating tumour cell recognition by infiltrating CTLs, these lesions were also analysed for MHC class I expression. The results
indicated that in most CIN lesions only a minority of CTLs are activated, whereas in some carcinomas a massive infiltration of activated, i.e.
granzyme B-positive, CTLs were observed. The percentage of activated CTLs was not related to expression of MHC class I on neoplastic
cells. These results suggest that in some carcinomas proper activation of CTLs occurs but that most likely local factors or immunoselection of
resistant neoplastic cells inhibit a proper response of CTLs to these neoplastic cells.
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Molecularbiological and epidemiological studies have shown that
infection with certain human papillomavirus (HPV) genotypes is
strongly associated with the development of cervical carcinoma
(Zur Hausen, 1994; IARC, 1995). Follow-up studies of women
with cytomorphological abnormal cervical smears indicate that
persistence ofoncogenic HPV types is conditional for the progres-
sion to high grade cervical intraepithelial neoplasia (CIN) III (Ho
et al 1995; Remmink et al 1995). However, the vast majority of
CIN lesions regress spontaneously. As in HPV-induced regressing
warts, CIN lesions are infiltrated by T cells, indicating that there
might be a local immune response against HPV (Coleman et al,
1994). A failure ofthe immune response against HPV might result
in persistence ofthe infection and a subsequent progression ofthe
lesion. An active role for the cellular immune system in the
prevention ofthe development ofcervical cancer is evidenced by a
higher incidence of HPV-associated premalignant lesions in
immunocompromised patients, such as AIDS patients and trans-
plant recipients (Halpert et al, 1986; Laga et al, 1992). However,
we and others have shown that major histocompatibility complex
(MHC) class I expression is frequently down-regulated on
neoplastic cells in malignant and premalignant lesions
(Connor and Stem, 1990; Cromme et al, 1993; Honma et al, 1994;
Keating et al, 1995). Lower expression or even complete absence
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of MHC class I molecules on tumour cells could affect their
lysis by cytotoxic T cells as has been shown in melanomas
(Rivoltini et al, 1995).
Cytotoxic Tcells (CTL) andnatural killer(NK) cells arethe major
effectorcells ineradicating virus-infected cells. ActivatedCD8+CTL
and NK cells.hold cytotoxic granules that contain the lytic products
perforin (Lichtenheld et al, 1988), granzymes: a group of highly
homologous serine proteases (Jenne and Tschopp, 1988) and the T-
cell-restricted intracellular antigen (TIA-1) (Tian et al, 1991).
Perforin, or pore-forming protein, causes cell lysis by generating
smallpores intheplasmamembraneofthetargetcell(Lichtenheldet
al, 1988). Recently, the role of granzymes in target cell death has
been extensively studied. Studies with granzyme B (GrB) knockout
mice have shown that granzyme B plays a crucial role in CTL and
NK-cell-mediated targetcell apoptosis (Heusel etal, 1994).
Granzymes are specifically expressed by activated CTLs, as has
been shown in vivo in autoimmune and infectious diseases, during
allograft rejection and in lymphomas (Griffiths and Muller, 1991;
Oudejans et al, 1996). Moreover, in vitro stimulation of lympho-
cytes with, for example, IL-2 or T-cell mitogens (MAb against
CD3 combined with PMA) induces granzyme mRNA and protein
expression (Liu etal, 1989). GrB is therefore agood markerforthe
identification of activated CTLs. TIA-1 is a recently identified
granule-associated RNA-binding protein that may also play a role
in target cell apoptosis (Tian et al, 1991). In contrast to GrB, TIA-
1 is constitutively expressed in more than 50% ofperipheral blood
CD8+ T cells and thus may define a subpopulation ofCD8+ T cells
possessing cytolytic potential (Anderson, 1996). However, expres-
sion ofTIA-1 is also strongly up-regulated after activation.
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Table 1 MHC class and infiltrate analysis in cervical carcinoma
Neoplastic cells Mean number of infiltrating cells per HPF
HC-A2 HC-10
CxCa number HPV HLA-Aa HLA-B/Ca CD3 CD8 TIA-1 GrB/CD3
1 18 + + 55.5 21.4 11.0 22.3
2 X + + 44.2 23.3 13.8 6.9
3 16,18 + + 46.7 27.5 8.4 7.5
4 X + + 24.7 13.2 4.5 4.4
5 16 + + 15.8 14.9 8.0 9.2
6 16 + + 8.0 3.6 5.1 1.6
7 18 + + 15.4 ND 8.2 6.0
8 16 + + 31.5 20.3 6.9 10.0
9 16 + + 28.6 31.8 10.8 6.0
10 6,16 + - 46.3 48.4 18.5 44.7
11 16 - + 6.2 4.9 5.7 1.7
12 16 - - 41.5 33.2 25.4 21.1
13 16 - - 20.0 18.5 13.7 3.1
14 6,16,18 - - 63.4 73.6 63.9 72.4
a+, Normal expression > 75% positive; +, heterogeneous expression 25-75% strongly reduced to negative; -, disturbed expression > 75% strongly reduced to
negative. ND, not done.
In the present study we have analysed the the number and acti-
vation state of T cells with a cytotoxic phenotype and NK cells
as determined by CD3, CD8, TIA-1 and GrB expression in
CIN lesions of increasing severity and cervical carcinoma.
Furthermore, the presence of activated CTL and NK cells was
related to MHC class I expression on neoplastic cells. In contrast
to what was expected, the number ofactivated CTLs was increased
in invasive carcinoma compared with CIN lesions. However, the
presence ofactivated CTLs was not related to MHC class I expres-
sion on the atypical cells.
MATERIALS AND METHODS
Patients and tissues
Fourteen squamous cell carcinomas ofthe uterine cervix and 24 CIN
lesions with different degrees of dysplasia (grade I, n = 7; grade II,
n = 7; and grade III, n = 10), randomly chosen from patients
attending the oncological gynaecological outpatient department of
the Free University Hospital, were analysed. The presence of HPV
DNA was assessed by ageneralprimer-based polymerase chainreac-
tion (PCR) method, as previously described (Van den Brule et al,
1990). Positive samples were subjected to a type-specific PCR iden-
tifying the following HPV types: HPV 6, 11, 16, 18, 31 and 33.
When HPV DNA was present, but not as one ofthe above-mentioned
types, an X was assigned. Formalin-fixed paraffin embedded tissues
were cut into 4-pm-thick sections and mounted on 3-amino-propyl-
triethoxy-silane-coated slides (APES; Sigma, MO, USA) forhaema-
toxylin and eosin (HE) and immunohistochemical staining.
Immunohistochemistry
Monostaining
The expression of HLA-A [HC-A2, mouse monoclonal antibody
(MAb), 1:500 (Stam et al, 1990)], HLA-B/C [mouse MAb HC-l0,
1:1000 (Stam et al, 1990)], CD3 (rabbit PolyAb, Dakopatts,
1:500), CD8 (mouse IgGI MAb, a generous gift from Dr Mason,
Oxford, UK, 1:10), TIA-1 (mouse MAb, coulter clone, UK, 1:250)
and granzyme B [mouse IgG2a MAb GrB7, 1:500; mouse IgGI
MAb GrB9 (Kummer et al, 1993, 1995)] were analysed as
described previously (Sale et al, 1994; Cromme et al, 1995).
Briefly, formalin-fixed paraffin-embedded sections were
deparaffinized using xylene; endogenous peroxidase was blocked
and antigen retrieval by microwave treatment was performed for
staining with the CD3, CD8, TIA-1 and GrB7 antibodies. Sections
stained with HC-A2 were pretreated with target unmasking fluid
(TUF, monosan, Uden, The Netherlands). Sections were subse-
quently washed andpreincubated with normal serum and incubated
with the primary antibody. Primary antibodies were detected using
biotinylated secondary antibodies, followed by horseradish peroxi-
dase (HRP)-conjugated streptavidin. HRP activity was detected by
incubating the slides with diaminobenzidine (DAB) and hydrogen
peroxide. The sections were counterstained with haematoxylin,
dehydrated and mounted. As a control, sections were incubated
with an irrelevant MAb ofthe appropriate subclass.
GrB9 and GrB7 showed a clear difference in specificity. GrB9
stained not only lymphocytes but also polymorphonuclear leuco-
cytes, owing to cross-reaction with homologous serine proteases
present in these cells (Kummer et al, 1995) and thereby hindering
easy scoring. GrB7 did not show such cross-reactivity and showed
a better sensitivity than GrB9. Therefore, the GrB7 monoclonal
antibody was used in this study.
Double staining
Double staining was performed for GrB and CD3 as described
previously (Oudejans et al, 1996). After boiling in a citrate buffer,
sections were simultaneously incubated with both antibodies.
After washing, GrB was detected using biotin-labelled goat anti-
mouse IgG2a antibody and streptavidin-HRP. HRP was visualized
by incubation for 10 min with 0.2 mg ml-' DAB, 0.002%
hydrogen peroxide 0.07% nickel chloride in 50 mm Tris-HCl,
pH 7.6, resulting in a DAB-nickel precipitate.
After blocking the remaining peroxidase activity with 0.3%
hydrogen peroxide-methanol for 15 min, the slides were lightly
fixed with 4% paraformaldehyde. CD3 was subsequently
detected using biotin-labelled swine anti-rabbit antibody and the
streptavidin-biotin horseradish peroxidase complex (ABC, Dako,
Glostrup, Denmark) respectively. HRP was visualized using DAB
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Figure 1 CIN II lesion (CIN 12; Table 2) stained for (A) granzyme B and (B) CD8. Only a few granzyme B-positive cells, indicated by the small arrows (A), are seen compared with the number of CD8-positive cells (B). (C) CIN II (CIN 13; Table 2) lesion stained for TIA-1. (D) CIN IlIl (CIN23; Table 2) lesion stained for granzyme B. Size bars represent 30gm
and hydrogen peroxide, resulting in a clear brown signal for CD3.
Subsequently, silver enhancement of the DAB-nickel precipitate
was performed as described previously (Merchentaler et al, 1989),
resulting in a black-staining signal for GrB. The sections were
counterstained with haematoxylin, dehydrated and mounted.
Interpretation of immunohistochemical staining
Immunohistochemical results were interpreted by three indepen-
dent observers. Briefly, MHC class I expression was scored
according to the percentage of neoplastic cells that showed
staining. Reduced staining on neoplastic cells was determined
compared with internal positive controls, such as normal squamous
epithelium and lymphocytes. Lesions were scored as positive (+)
when themajority ofneoplastic cells (>75%) showed membranous
staining; as heterogeneous (±) when areas of positively stained
neoplastic cells were observed next to negative areas (the latter
constituting 25-75% of the neoplastic cells); as negative (-) when
the majority of the neoplastic cells (> 75%) showed no membra-
nous staining.
Infiltrate analysis ofthe CIN lesions was performed interpreting
at least ten high-power fields (HPF, 400x) or, when the biopsy was
small, the complete area ofdysplastic epithelium. Where possible,
each HPF consisted of at least 50% epithelial cells. In carcinomas
ten HPFs were systematically randomly selected using an inter-
active video-overlay-based measuring system (Q-PRODIT, Leica,
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Table 2 MHC class and infiltrate analysis of the CIN lesions
Neoplastic cells Mean number of infiltrating cells per HPF
HC-A2 HC-10
Grade HPV HLA-Aa HLA-B/Ca CD3 CD8 TIA-1 GrB
CIN
1 18, X + + 13.3 5.3 8.2 4.5
2 X + + 15.5 14.0 3.9 1.3
3 Negative + + 9.1 18.9 ND 1.6
4 6 + + 17.4 7.1 2.6 0.8
5 Negative + + 12.2 11.8 5.3 5.6
6 6 + - 14.8 5.4 12.6 1.0
7 Negative + - 24.6 14.4 4.4 0.7
CIN II
8 16 + + 42.3 33.1 11.6 0.8
9 18, X + + 23.8 19.0 5.2 1.6
10 X + + 30.3 17.0 12.7 1.4
11 16 + + 28.6 23.4 1.8 0.7
12 16,31 + + 27.3 34.3 ND 3.0
13 33 + - 24.6 14.3 5.3 2.2
14 16 + - 25.1 20.5 6.2 2.3
CIN Ill
15 16 + + 40.9 37.7 13.1 1.8
16 6,16 + + 18.1 12.6 0.4 0.9
17 X + + 8.5 7.1 5.3 1.7
18 16 + + 21.6 17.3 8.6 2.6
19 16 + + 38.1 21.7 7.9 2.4
20 31 + + 17.1 13.3 6.8 2.4
21 33 + - 17.5 10.1 5.3 1.1
22 16 + - 8.7 2.6 2.4 0
23 33 + - 14.0 15.4 3.1 1.5
24 16 + - 13.7 11.1 3.8 0.3
a+, Normal expression > 75% positive; _, heterogeneous expression 25-75% strongly reduced to negative; -, disturbed expression > 75% strongly reduced to
negative. ND, not done.
Cambridge, UK). Infiltrating cells positive for CD3, CD8, TIA-1,
GrB7 and CD3/GrB7 double-positive cells were counted by two
independent observers.
Statistical methods
The expression of the different markers in the different grades of
dysplasia were compared using the Mann-Whitney two-sample
test and the Wilcoxon signed rank test.
RESULTS
HPV DNA detection
Three CIN lesions, all CIN I, were HPV negative. The HPV types
detected in the other CIN lesions were HPV 6, 16, 18, 31, 33 with
the exception of four CIN lesions in which a type other than HPV
6, 11, 16, 18, 31 and 33 (designatedX) was detected (Table 2). All
carcinomas were HPV positive: in 12 cases a high-risk type was
present (HPV 16 or 18) and in two carcinomas a HPV-X (Table 1).
Granzyme B and TIA-1 activity in cervical intra-
epithelial neoplasia
A few GrB+cells were observed in CIN lesions both in stroma and
infiltrating in the neoplastic areas (Table 2). GrB+ cells were
frequently detected under the squamous-columnarjunction. In the
majority of the CIN lesions, GrB+lymphocytes were sporadically
detected, in spite of substantial infiltration by CD3+CD8+CTILs in
the dysplastic area (Figure 1A and B, Table 2). In general, the
staining intensity of the GrB+ lymphocytes in CIN lesions was
much weaker than that ofGrB+cells in carcinomas. Not only were
CTLs found in or underthe dysplastic epitheliumbut also consider-
able numbers of CTLs were detected under the normal squamous
epithelium. These cells werenearly all GrB-(not shown). The mean
number of TIA-1-positive cells in CIN I-III was significantly
higher than the mean number ofGrB+cells (6.2 vs 1.7; P = 0.0001,
Wilcoxon signed rank test; Fig. IC and D, Table 2). There were no
differences among the different grades of CIN. In two cases, there
were more TIA-l-positive cells than CD8-positive cells, probably
indicating the presence ofCD3- and CD8-negative NK cells.
Granzyme B and TIA-1 activity in carcinomas
The number of tumour-infiltrating, granzyme B-expressing,
lymphocytes varied substantially between the different carci-
nomas, ranging fromjust afew lymphocytes per HPF (i.e. CxCa 2,
4, 6 and 13; Table 1) to a massive infiltration over 40 GrB+
lymphocytes per HPF (i.e CxCa 10 and 14; Table 1 and Figure
2A). In the majority of the tumours, GrB+ cells were located
predominantly in the neoplastic area in close contact with the
tumour cells (Figure 2A). In the stromal tissue, a marked intra- and
perivascular localization ofGrB+cells was observed (Figure 2D).
To determine whether granzyme B-expressing lymphocytes
represented CD3+ T lymphocytes or CD3- NK cells, double
staining with GrB7 and CD3 wasperformed(Figure 2A andD). To
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Figure 2 An HLA-A negative (A-C) and a HLA-A positive (D-F) carcinoma were stained for both CD3 (brown) and granzyme B (black) (A and D), CD8 (B and
E) and for HLA-A (C and F). The stained cells in C are MHC class I-positive infitrating macrophages and lymphocyes, acting as an internal positive control. In D
GrB+ CD3+ CTLs are indicated by the small arrows and a GrB+ CD3- NK cell with a LGL morphology is indicated by a large arrow. Size bars represent 30gm
discriminate between CD4+ T-helper lymphocytes and CD8+ cyto-
toxic T lymphocytes, CD8 staining was performed on subsequent
tissue sections (Figure 2B and E).
In general, the majority ofthe GrB+ lymphocytes, infiltrating in
the neoplastic area stained positive for CD3 (Figure 2A). CD8
staining of subsequent sections showed that the CD3+GrB+ cells
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Figure 3 Mean CD8/CD3, TIA-1/CD3 and GrB/CD3 ratios of infiltrating cells
in CIN lesions (CINI-III,*) and in cervical carcinomas ( ). Significant
differences are indicated by the asterisks
also expressed CD8 (Figure 2A and B), indicating that these repre-
sent activated CTLs. GrB+ but CD3- lymphocytes, representing
NK cells, were observed in all tumours. In most tumours, they
were a minor population compared with the number of CD3+ GrB+
lymphocytes (not shown). GrB+CD3- NK cells showed a distinct
morphology of large granular lymphocytes and showed an intense
granzyme B staining (Figure 2D).
The mean number of TIA-1-positive cells was not significantly
different from the mean number of GrB+ cells (14.6 vs 14.9; P =
0.36, Wilcoxon signed rank test; Table 1). The percentage of CD8+
lymphocytes that are positive for granzyme B varies between the
different tumours from approximately 15% in C x Ca 13, to up to
100% in CxCa 10 (Table 1). These results indicate that in most
carcinomas the majority of the CD8+ cells with cytotoxic potential
are indeed activated. In contrast, only a minority of the CTL
present in stroma (< 5%) showed an activated profile.
The ratio of infiltrating CD8/CD3 cells was similar in the
CIN lesions and in the carcinomas. However, the mean TIA-l/
CD3 ratio was slightly, though not significantly, higher in the
carcinomas than in the CIN lesions (Figure 3, P = 0.083, Mann-
Whitney two sample test). The GrB7/CD3 ratio was significantly
higher in the carcinomas than in the CIN lesions (Figure 3;
P < 0.0001, Mann-Whitney two-sample test).
MHC class I expression on neoplastic cells
All CIN lesions were positive for HLA-A and/or HLA-B/C: three
(43%) CIN I; five (72%) CIN II; and nine (82%) CIN III lesions
showed heterogeneous expression of MHC class I or a complete
loss for HLA-B/C alone (Table 2).
In 5 out of 14 carcinomas (35%), normal HLA-A and HLA-B/C
expression was observed and six (43%) showed heterogeneous
expression. Three (21%) carcinomas were completely negative for
MHC class I (Table 1).
As CTL killing is usually MHC class I restricted, infiltration of
GrB+ cells was related to HLA-A and HLA-B/C expression. No
correlation between HLA class I expression and the number of
granzyme B-expressing cells was found. Numerous infiltrating
GrB+ CTLs can be observed in both MHC class I-negative tumours
(Figure 2A-C) as well as in tumours with a normal MHC class I
expression (Figure 2D-F). The number of CD8+ cells alone did not
correlate with MHC class I expression either.
DISCUSSION
In this study the question was assessed whether there is a role for
cytotoxic T cells in (pre)malignant lesions of the cervix. We found
that the percentage of activated CD3+ cytotoxic T cells as demon-
strated by CD8, TIA-1 and GrB expression was higher in invasive
carcinoma than in premalignant CIN I-III. The fact that in a
previous study (Cromme et al, 1995) fewer activated CTLs were
detected is due to the antibody used, i.e. GrB9, which is less
specific and sensitive than the GrB7 MAb used in this study.
Interestingly, most CIN lesions were infiltrated by a substantial
number of CD8+ lymphocytes in the dysplastic epithelium of
which approximately 50% expressed TIA-1 (Figure 3), but GrB+
lymphocytes were only sporadically present. These results indicate
that in CIN only a minority of infiltrating CD8+ lymphocytes with
cytotoxic potential are indeed activated. No clear relation could be
demonstrated between MHC class I expression and the number of
activated CTLs infiltrating in the epithelium.
In most carcinomas numerous GrB-infiltrating lymphocytes
were present. The number varied substantially, ranging from just a
few lymphocytes per HPF to a massive infiltration up to 70 GrB+
lymphocytes per HPF. Phenotyping showed that the majority of
GrB+ lymphocytes were CD8+ CTL (Figure 2), although, in some,
a substantial number of NK cells were present (data not shown).
The percentage of CD8+ lymphocytes that were positive for GrB
varied between the different tumours from approximately 15% up
to 100%. The number of TIA-l-expressing cells was not signifi-
cantly different from the number of GrB-expressing cells, indi-
cating that in carcinomas the majority of CTLs with cytotoxic
phenotype (TIA-1 positive) are indeed activated (GrB+). However,
in some carcinomas only a minority of CD8+ T cells expressed
GrB and/or TIA-1, indicating that in these carcinomas a lack of
CTL activation is observed. Thus, compared with CIN, in carci-
nomas more CD8+ cells with cytotoxic potential and significantly
more activated CTLs were found infiltrating in the epithelium
(Figure 3). In the stromal tissue, a marked intra- and perivascular
localization was observed (Figure 2D), indicating that a proportion
of the cytotoxic lymphocytes were activated before or during
infiltration of the tumour.
Most CIN lesions showed poor infiltration of GrB+ cells in the
dysplastic epithelium. The question arises whether these few acti-
vated CTLs upon recognition of the virus-infected keratinocytes,
are sufficient to induce regression ofthese lesions. A single CTL is
capable of killing many different targets one after another, and a
recent study has shown that the granzyme-perforin granule
pathway can be sustained during T-cell killing (Isaaz et al, 1995).
Although the relatively low number of activated CTLs suggest that
CTLs do not play an important role in the spontaneous regression
of CIN lesions, it cannot be ruled out that a limited number of
activated CTLs can kill a sufficient number of keratinocytes in
these lesions to initiate regression.
In addition, the presence of large number of activated CTLs
detected in some of the cervical carcinomas is not sufficient to
eradicate the tumour. Several explanations for this observation are
possible. First, it could be simply that there are still too few CTLs and
that the neoplastic cells proliferate faster than CTLs can kill them.
Secondly, MHC class I alleles are down-regulated on the surface
of neoplastic cells, as has been previously shown in several studies
for both premalignant and malignant lesions (Connor and Stern,
1990; Cromme et al, 1993). This lower expression or even
complete absence of MHC class I molecules on tumour cells could
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affect their recognition and lysis by CTLs (Rivoltini et al, 1995). In
agreement with the above-mentioned studies, most carcinomas
showed (partial) down-regulation of MHC class I alleles, but no
relation between the presence ofactivated CTLs and expression of
MHC class I in the carcinomas tested was observed. High numbers
of GrB+CD3+ CTLs were observed in contact with keratinocytes
that were completely negative for MHC class I (Figure 2A-C) as
well as in neoplastic areas expressing normal levels ofMHC class
I (Figure 2D-F). Although studies on the effector mechanisms of
NK cells indicate that a down-regulation ofparticular MHC class I
alleles makes the neoplastic cells more sensitive to NK-cell-
mediated lysis (Lanier and Phillips, 1996), NK cells were not
found in higher frequencies in MHC class I down-regulated
neoplastic areas (not shown). Most probably, in those carcinomas
in which there is a massive activated CTL infiltrate but a lack of
MHC class I expression on the neoplastic cells, immunoselection
by CTLs ofresistant tumour cells has taken place. A similar mech-
anism has been suggested in Epstein-Barr virus (EBV)-associated
Hodgkin's disease (Poppema and Visser, 1994). Alternatively,
CTLs may detect lower MHC class I levels than are detected by the
antibodies used in this study. Furthermore, shedding ofMHC class
I or shed tumour antigen-antibody complexes has been postulated
to be a blocking factor that can interfere with the immune response
(Giacomini et al, 1984).
Thirdly, resistance of tumour cells can occur owing to other
factors than those related to MHC class I, for example CTL-
induced apoptosis is dependent on the state of activation of the
target cell and its commitment into the mitotic cycle (Nishioka and
Welsh, 1994) and target cell mutants have been described that are
recognized by, and provide an antigenic stimulus to, the CTLs,
whereas they have lost the capacity to respond by dying (Ucker et
al, 1995). Also an, at present unknown, protective membrane
protein that impairs perforin-mediated cytolysis has been
described for lymphoid cells (Muller and Tschopp, 1994), but it is
still not known whether other cell types possess such protective
molecules. Recently, it was shown that the expression of bcl-2, a
marker for inhibition ofprogrammed cell death, increased with the
severity of cervical (pre)malignant lesions. These results indicate
that bcl-2 might play a role in rendering transformed keratinocytes
resistant to apoptotic cell death (ter Harmsel et al, 1996).
Finally, the observed massive GrB+ T-cell infiltrate might be part
ofa general inflammatory reaction, due to local cytokine production,
rather than a consequence of a specific immune response. Although
synthesis oflytic proteins and the formation oflytic granules is trig-
gered by recognition ofa target cell by the T-cell receptor ofthe CTL
precursor (Isaaz et al, 1995), non-specific activation, for example
by interleukin 2, is possible (Kummer et al, 1995). Interleukin 2
production in these tumours is currently under investigation.
Some carcinomas in this study have low numbers of activated
CTLs, in spite ofa substantial CD8+ T-cell infiltrate. T-helper type 1
(Th1) cells produce cytokines principally providing help for CTL-
mediated responses, whereas Th2 cells provide help mainly for anti-
body-mediated responses. Cytokines, produced, for example, by the
tumour cells, such as interleukin 10 and transforming growth factor-
,B (TGF-f3), can shift the local balance towards a more Th2-type
response ordirectly inhibit CTL activation and thus explain a lack of
infiltrating functional activated CTLs as was previously suggested
for EBV-specific CTLs in EBV-positive Hodgkin's disease (Frisan
et al, 1995; Oudejans et al, 1996). We are currently investigating this
hypothesis. Preliminary RT PCR results show that local production
of the immunosuppressive cytokine TGF-j (Xie and Gallagher,
1994) might be responsible for a lack of CTL activation in these
carcinomas. Furtherin vitro studies are necessary to substantiate this
observation.
In the mouse, it has been shown forcytopathic viruses [vesicular
stomatitis virus (VSV) and semliki forest virus (SFV)] that soluble
mediators play a role in eradication of the virus rather than cell-
mediated factors, although the cell-mediated immune response
plays an important role in the eradication ofnon-cytopathic viruses
such as lymphocytic choriomeningitis virus (LCMV) (Kagi et al,
1995). The lack of CTL activation in CIN compared with most
carcinomas might be due to these mechanisms. In low-grade CIN,
HPV infection is thought to be a productive lytic infection,
possibly because it does not allow enough time for the infected cell
to process and present HPV antigens. Thus, at this stage, non-lytic
T-cell-dependent soluble mediators such as cytokines (interferon-y)
and neutralizing antibodies might play a more important role.
As HPV infection is non-cytopathic in carcinomas, allowing
processing and presentation ofHPV antigens, cell-mediated factors
might play a more important role at this stage ofthe disease.
In conclusion, our results show that there is a distinct infiltration
by CD8+ T-lymphocytes in both CIN lesions and carcinoma of the
cervix, but surprisingly the percentage of activated T-cells, as
measured by GrB expression, increases from CIN lesions to carci-
nomas. These results indicate that in certain cervical carcinomas,
local factors, presumably cytokines or immunoselection of the
tumour cells, are responsible for escaping the immune response,
rather than a lack ofCTL activation a priori. The role ofthese local
factors is currently under investigation in our laboratory.
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